Mitosis-specific negative regulation of epidermal growth factor receptor, triggered by a decrease in ligand binding and dimerization, can be overcome by overexpression of receptor

被引:50
作者
Kiyokawa, N [1 ]
Lee, EK [1 ]
Karunagaran, D [1 ]
Lin, SY [1 ]
Hung, MC [1 ]
机构
[1] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT TUMOR BIOL,BREAST CANC BASIC RES PROGRAM,HOUSTON,TX 77030
关键词
D O I
10.1074/jbc.272.30.18656
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The function of epidermal growth factor receptor (EGFR) was found to be negatively regulated in M phase in which it showed less phosphotyrosine content and reduced intrinsic kinase activity accompanied by retarded electrophoretic mobility owing to total hyperphosphorylation, Ligand induced autophosphorylation and downstream signaling of EGFR were tightly suppressed in M phase due to a decrease in ligand binding affinity and the inability of epidermal growth factor (EGF) to induce receptor dimerization. There was no change in the number of surface-exposed EGF receptors between G(0)/G(1) and M phases of the cell cycle. Hyperphosphorylation (due to serine and/or threonine phosphorylation) correlates with the unresponsiveness of cells to EGF-mediated stimulation of tyrosine phosphorylation in cells that express the normal or basal level of EGFR. This M phase-specific negative regulation was overcome by overexpression of EGFR, which was responsive to ligand throughout the cell cycle and revealed ligand-induced signaling in the M phase. These findings indicate that EGFR does not respond to ligand stimulation in M phase and suggest that a negative regulation of ligand-receptor interactions in M phase may control the normal function of receptor tyrosine kinase and that receptor overexpression will disrupt this cell cycle-dependent regulation of receptor tyrosine kinases.
引用
收藏
页码:18656 / 18665
页数:10
相关论文
共 56 条
  • [1] TUMOR PROMOTER AND EPIDERMAL GROWTH-FACTOR STIMULATE PHOSPHORYLATION OF THE C-ERBB-2-GENE PRODUCT IN MKN-7 HUMAN ADENOCARCINOMA CELLS
    AKIYAMA, T
    SAITO, T
    OGAWARA, H
    TOYOSHIMA, K
    YAMAMOTO, T
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (03) : 1019 - 1026
  • [2] THE NEU ONCOGENE ENCODES AN EPIDERMAL GROWTH-FACTOR RECEPTOR-RELATED PROTEIN
    BARGMANN, CI
    HUNG, MC
    WEINBERG, RA
    [J]. NATURE, 1986, 319 (6050) : 226 - 230
  • [3] EVALUATION OF EPIDERMAL GROWTH-FACTOR RECEPTORS IN BLADDER-TUMORS
    BERGER, MS
    GREENFIELD, C
    GULLICK, WJ
    HALEY, J
    DOWNWARD, J
    NEAL, DE
    HARRIS, AL
    WATERFIELD, MD
    [J]. BRITISH JOURNAL OF CANCER, 1987, 56 (05) : 533 - 537
  • [4] HUMAN P53 IS PHOSPHORYLATED BY P60-CDC2 AND CYCLIN-B-CDC2
    BISCHOFF, JR
    FRIEDMAN, PN
    MARSHAK, DR
    PRIVES, C
    BEACH, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (12) : 4766 - 4770
  • [5] ALTERED PHOSPHORYLATION AND ACTIVATION OF PP60C-SRC DURING FIBROBLAST MITOSIS
    CHACKALAPARAMPIL, I
    SHALLOWAY, D
    [J]. CELL, 1988, 52 (06) : 801 - 810
  • [6] PHOSPHORYLATION OF THE RETINOBLASTOMA GENE-PRODUCT IS MODULATED DURING THE CELL-CYCLE AND CELLULAR-DIFFERENTIATION
    CHEN, PL
    SCULLY, P
    SHEW, JY
    WANG, JYJ
    LEE, WH
    [J]. CELL, 1989, 58 (06) : 1193 - 1198
  • [7] COCHET C, 1984, J BIOL CHEM, V259, P2553
  • [8] COOPER JA, 1983, METHOD ENZYMOL, V99, P387
  • [9] COUNTAWAY JL, 1992, J BIOL CHEM, V267, P1129
  • [10] DERYNCK R, 1987, CANCER RES, V47, P707